By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company AK Medical Holdings Limited

AK Medical Holdings Limited (1789.HK)

HKSE Market Data in HKD, Fundamentals in CNY
$5.71
+$0.11
+1.96%
Last Update: 1 Sept 2025, 05:30
$6.37B
Market Cap
0.00
P/E Ratio (TTM)
1.26%
Forward Dividend Yield
$3.61 - $7.24
52 Week Range

1789.HK Stock Price Chart

Explore AK Medical Holdings Limited interactive price chart. Choose custom timeframes to analyze 1789.HK price movements and trends.

1789.HK Company Profile

Discover essential business fundamentals and corporate details for AK Medical Holdings Limited (1789.HK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

20 Dec 2017

Employees

950.00

CEO

Zhijiang Li

Description

AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. It offers knee, hip, and spine replacement implants; and 3D-printed products, such as 3D-printed hip replacement implants, 3D-printed artificial vertebral bodies, and 3D-printed spinal interbody cages. The company also distributes third party orthopedic products; and manufactures surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China. AK Medical Holdings Limited is a subsidiary of Ximalaya Limited.

1789.HK Financial Timeline

Browse a chronological timeline of AK Medical Holdings Limited corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 27 Aug 2025

EPS came in at $0.15 matching the estimated $0.15, while revenue for the quarter reached $760.73M , missing expectations by -1.72%.

Dividend declared on 23 Jun 2025

A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 18 Jul 2025.

Earnings released on 25 Mar 2025

EPS came in at $0.13 surpassing the estimated $0.13 by +0.23%, while revenue for the quarter reached $733.25M , missing expectations by -1.29%.

Earnings released on 29 Aug 2024

EPS came in at $0.13 surpassing the estimated $0.13 by +4.58%, while revenue for the quarter reached $711.30M , beating expectations by +1.34%.

Dividend declared on 24 Jun 2024

A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 18 Jul 2024.

Earnings released on 26 Mar 2024

EPS came in at $0.05 falling short of the estimated $0.06 by -12.72%, while revenue for the quarter reached $482.04M , beating expectations by +7.66%.

Earnings released on 22 Aug 2023

EPS came in at $0.13 surpassing the estimated $0.12 by +12.53%, while revenue for the quarter reached $733.01M , beating expectations by +6.42%.

Dividend declared on 21 Jun 2023

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 18 Jul 2023.

Earnings released on 28 Mar 2023

EPS came in at $0.08 surpassing the estimated $0.06 by +31.45%, while revenue for the quarter reached $584.46M , missing expectations by -1.70%.

Earnings released on 30 Aug 2022

EPS came in at $0.11 surpassing the estimated $0.07 by +61.29%, while revenue for the quarter reached $530.72M , missing expectations by -5.80%.

Dividend declared on 17 Jun 2022

A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 13 Jul 2022.

Earnings released on 25 Mar 2022

EPS came in at -$0.02 , while revenue for the quarter reached $384.21M , beating expectations by +8.45%.

Earnings released on 24 Aug 2021

EPS came in at $0.12 falling short of the estimated $0.12 by -0.17%, while revenue for the quarter reached $537.44M , beating expectations by +3.89%.

Dividend declared on 17 Jun 2021

A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 13 Jul 2021.

Earnings released on 23 Mar 2021

EPS came in at $0.16 falling short of the estimated $0.21 by -24.70%, while revenue for the quarter reached $660.80M , missing expectations by -14.71%.

1789.HK Stock Performance

Access detailed 1789.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run